Literature DB >> 16000516

Molecular mycological diagnosis and correct antimycotic treatments.

Nicasio Mancini, Cristina M Ossi, Mario Perotti, Massimo Clementi, Daniel B DiGiulio, Joanna M Schaenman, Jose G Montoya, Nancy B McClenny, Gerald J Berry, Laurence F Mirels, Michael G Rinaldi, Annette W Fothergill.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16000516      PMCID： PMC1169111          DOI： 10.1128/JCM.43.7.3584-3585.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  10 in total

1.  Contaminations occurring in fungal PCR assays.

Authors:  J Loeffler; H Hebart; R Bialek; L Hagmeyer; D Schmidt; F P Serey; M Hartmann; J Eucker; H Einsele
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Rapid identification of fungi by sequencing the ITS1 and ITS2 regions using an automated capillary electrophoresis system.

Authors:  T M Pryce; S Palladino; I D Kay; G W Coombs
Journal:  Med Mycol       Date:  2003-10       Impact factor: 4.076

Review 3.  Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories.

Authors:  Wayne Dimech; D Scott Bowden; Brian Brestovac; Keith Byron; Greg James; Darren Jardine; Theo Sloots; Elizabeth M Dax
Journal:  Pathology       Date:  2004-02       Impact factor: 5.306

Review 4.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Introducing a molecular test into the clinical microbiology laboratory: development, evaluation, and validation.

Authors:  Betty A Forbes
Journal:  Arch Pathol Lab Med       Date:  2003-09       Impact factor: 5.534

6.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

7.  In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

8.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

Review 9.  Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.

Authors:  Joanna M Schaenman; Daniel B DiGiulio; Laurence F Mirels; Nancy M McClenny; Gerald J Berry; Annette W Fothergill; Michael G Rinaldi; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 10.  History of the development of azole derivatives.

Authors:  J A Maertens
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067
  10 in total
  2 in total

1.  Molecular diagnosis of polymicrobial sepsis.

Authors:  Nicasio Mancini; Silvia Carletti; Nadia Ghidoli; Paola Cichero; Cristina M Ossi; Rossella Ieri; Elena Poli; Roberto Burioni; Massimo Clementi
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

2.  Mycetoma.

Authors:  Angoori Gnaneshwar Rao
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.